Almirall SA (ALM) Stock Price & News

Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia

About Almirall SA

CEOGianfranco Nazzi | Carlos Gallardo Piqué

Employees2.11K

Founded1944

Headquarters-

SectorPharmaceutical industry

Websitealmirall.com

All values in EUR	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	277.27M	262.23M	288.93M	292.40M
Cost of goods sold	35.86M	157.74M	-27.67M	104.30M
Cost of revenue	35.86M	157.74M	-27.67M	104.30M
Research and development expenses	-35.50M	102.40M	-102.40M	34.80M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8.95M	234.95M	-102.92M	121.60M
Operating expense	232.48M	81.32M	310.92M	158.10M
Total operating expenses	268.35M	239.05M	283.25M	262.40M
Operating income	8.92M	23.18M	5.69M	30.00M
Other non operating income	-3.90M	8.20M	3.36M	-1.70M
EBT including unusual items	8.33M	20.97M	9.35M	23.40M
EBT excluding unusual items	1.79M	29.41M	5.78M	24.50M
Income tax expense	3.35M	8.45M	2.29M	8.10M
Effective tax rate	40.20%	40.30%	24.54%	34.62%
Other operating expenses	182.66M	-179.66M	365.05M	1.70M
Net income	4.98M	12.52M	7.05M	15.30M
Net profit margin	1.80%	4.77%	2.44%	5.23%
Earnings per share	-	-	-	-
Interest and investment income	2.13M	1.37M	1.35M	1.00M
Interest expense	-4.21M	-3.89M	-5.05M	-4.50M
Net interest expenses	-2.08M	-2.52M	-3.70M	-3.50M
Depreciation and amortization charges	76.38M	-76.38M	151.18M	-
EBITDA	39.04M	69.66M	23.70M	67.50M
Gain or loss from assets sale	-	-	199.00K	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research